ADVANSE Trademark

Trademark Overview


On Friday, May 25, 2018, a trademark application was filed for ADVANSE with the United States Patent and Trademark Office. The USPTO has given the ADVANSE trademark a serial number of 87936976. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Wednesday, January 23, 2019. This trademark is owned by Concordia International RX (UK) Limited. The ADVANSE trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

A full line of pharmaceuticals for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, acute enterocolitis, duodenal ulcer, and irritable bowel syndrome being irritable colon, spastic colon, mucous colitis; anti-inflammatory medicines, immunosuppressive agents, namely, corticosteroids; pharmaceutical preparations for the treatment of cancers and abnormal cells

Medical devices, namely, lasers and fibre-optic wires and cables for use in photodynamic therapy with the administration of a photosensitizing agent for the treatment of cancer
advanse

General Information


Serial Number87936976
Word MarkADVANSE
Filing DateFriday, May 25, 2018
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateWednesday, January 23, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 25, 2018

Trademark Statements


Goods and ServicesA full line of pharmaceuticals for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, acute enterocolitis, duodenal ulcer, and irritable bowel syndrome being irritable colon, spastic colon, mucous colitis; anti-inflammatory medicines, immunosuppressive agents, namely, corticosteroids; pharmaceutical preparations for the treatment of cancers and abnormal cells
Goods and ServicesMedical devices, namely, lasers and fibre-optic wires and cables for use in photodynamic therapy with the administration of a photosensitizing agent for the treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, January 23, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code8 - Abandoned
Class Status DateWednesday, January 23, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameConcordia International RX (UK) Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLondon EC4N7BL
GB

Party NameConcordia International RX (UK) Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon EC4N7BL
GB

Trademark Events


Event DateEvent Description
Wednesday, January 23, 2019ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Wednesday, January 23, 2019ABANDONMENT - AFTER PUBLICATION
Tuesday, January 22, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, January 22, 2019TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, December 25, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 25, 2018PUBLISHED FOR OPPOSITION
Wednesday, December 5, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 16, 2018ASSIGNED TO LIE
Wednesday, October 31, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 31, 2018EXAMINER'S AMENDMENT ENTERED
Wednesday, October 31, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 31, 2018EXAMINERS AMENDMENT E-MAILED
Wednesday, October 31, 2018EXAMINERS AMENDMENT -WRITTEN
Friday, October 26, 2018PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, October 2, 2018WITHDRAWN FROM PUB - OG REVIEW QUERY
Saturday, September 15, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 15, 2018ASSIGNED TO EXAMINER
Sunday, June 3, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 29, 2018NEW APPLICATION ENTERED IN TRAM